Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zivin, J. A.
Right arrow Articles by Waud, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zivin, J. A.
Right arrow Articles by Waud, D. R.

Stroke, Vol 23, 767-773, Copyright © 1992 by American Heart Association


ARTICLES

Quantal bioassay and stroke

JA Zivin and DR Waud
Department of Neurosciences, University of California, San Diego, School of Medicine, La Jolla 92093-0624.

BACKGROUND: Experimental investigation of stroke, in particular the evaluation of therapeutic maneuvers, is difficult because even well- controlled experiments show considerable variability. Optimal use of resources requires efficient statistical analysis. SUMMARY OF REVIEW: A body of experience in pharmacology that is directly applicable to stroke studies is reviewed. The general approach, though well known to pharmacologists, is less familiar to neurologists. This paper attempts to give a survey so that neurologists encountering studies using this general class of analysis will better be able to put the technique into context. The general nature of a quantal bioassay is described, the underlying conceptual models are discussed, and specific examples are given. CONCLUSIONS: The pharmacologist's approach to the analysis of quantal bioassays can easily be adapted to the quantification of results in studies of stroke.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
T. Fuchigami, M. Kakinohana, S. Nakamura, K. Murata, and K. Sugahara
Intrathecal nicorandil and small-dose morphine can induce spastic paraparesis after a noninjurious interval of spinal cord ischemia in the rat.
Anesth. Analg., April 1, 2006; 102(4): 1217 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. W.G. Elbers, P. de Haan, I. Vanicky, D. Legemate, and M. Dzoljic
Effect of Temporary Visceral Ischemia on Spinal Cord Ischemic Damage in the Rabbit.
Ann. Thorac. Surg., March 1, 2006; 81(3): 910 - 917.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. A. Lapchak and J. A. Zivin
Ebselen, a Seleno-Organic Antioxidant, Is Neuroprotective After Embolic Strokes in Rabbits: Synergism With Low-Dose Tissue Plasminogen Activator
Stroke, August 1, 2003; 34(8): 2013 - 2018.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Kakinohana, T. Fuchigami, S. Nakamura, T. Sasara, T. Kawabata, and K. Sugahara
Intrathecal Administration of Morphine, but Not Small Dose, Induced Spastic Paraparesis After a Noninjurious Interval of Aortic Occlusion in Rats
Anesth. Analg., March 1, 2003; 96(3): 769 - 775.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. A. Lapchak, D. M. Araujo, S. Pakola, D. Song, J. Wei, and J. A. Zivin
Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits
Stroke, September 1, 2002; 33(9): 2279 - 2284.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. A. Lapchak, D. M. Araujo, D. Song, and J. A. Zivin
Neuroprotection by the Selective Cyclooxygenase-2 Inhibitor SC-236 Results in Improvements in Behavioral Deficits Induced by Reversible Spinal Cord Ischemia
Stroke, May 1, 2001; 32(5): 1220 - 1225.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. A. Lapchak, D. F. Chapman, S. Y. Nunez, J. A. Zivin, and C. Y. Hsu
Dehydroepiandrosterone Sulfate Is Neuroprotective in a Reversible Spinal Cord Ischemia Model : Possible Involvement of GABAA Receptors Editorial Comment: Possible Involvement of GABAA Receptors
Stroke, August 1, 2000; 31(8): 1953 - 1957.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Lyden, C. Shin, C. Jackson-Friedman, S. Hassid, A. Chong, and R. L. Macdonald
Effect of Ganaxolone in a Rodent Model of Cerebral Hematoma Editorial Comment
Stroke, January 1, 2000; 31(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. A. Zivin
Thrombolytic stroke therapy: Past, present, and future
Neurology, July 1, 1999; 53(1): 14 - 14.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. D. Lyden, C. Jackson-Friedman, L. Lonzo-Doktor, and J. P. Muizelaar
Medical Therapy for Intracerebral Hematoma With the {gamma}-Aminobutyric Acid-A Agonist Muscimol
Stroke, February 1, 1997; 28(2): 387 - 391.
[Abstract] [Full Text]


Home page
StrokeHome page
J. Aronowski, R. Strong, J.C. Grotta, and H. A. Kontos
Combined Neuroprotection and Reperfusion Therapy for Stroke: Effect of Lubeluzole and Diaspirin Cross-Linked Hemoglobin in Experimental Focal Ischemia
Stroke, September 1, 1996; 27(9): 1571 - 1577.
[Abstract] [Full Text]